- P-ISSN 1010-0695
- E-ISSN 2288-3339
Background: Breast cancer is a treatable disease, but some women reject conventional treatment in favor of unproven "alternative therapies," which may have serious implications for their survival. Therefore, a process is needed to lead them to more appropriate treatment choices. Case presentation: Here, we present the case of a 51-year-old Korean female diagnosed with early-stage breast cancer (stage IIB, T2N1M0) in Nov. 2015. She refused a standard surgical resection together with chemotherapy and opted instead for moxibustion by nonmedical personnel. Consequently, her preference for alternative therapy without conventional treatment exacerbated her disease. Just a little over a year later, integrative cancer treatment, including chemotherapy based on histological founding, and complementary treatment, comprised of acupuncture, moxibustion, and herbal medicine, were administered for 5 months. Finally, she successfully underwent modified radical mastectomy showing a pathological complete response. She received only adjuvant chemotherapy without any alternative medicine afterwards, and she maintained a good status without recurrence. Conclusion: In the case of breast cancer patients who are resistant to surgery and chemotherapy, integrative therapy considering adverse effects from conventional treatment should be preferred to bitter opposition to alternative medicine.
1. DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA: a cancer journal for clinicians. 2017;67(6):439-48.
2. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA: a cancer journal for clinicians. 2017;67(1):7-30.
3. van Kleffens T, van Leeuwen E, Physicians'evaluations of patients' decisions to refuse oncological treatment. Journal of medical ethics. 2005;31(3):131-6.
4. Bickell NA, Weidmann J, Fei K, Lin JJ, Leventhal H. Underuse of breast cancer adjuvant treatment:patient knowledge, beliefs, and medical mistrust. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(31):5160-7.
5. Helms RL, O'Hea EL, Corso M. Body image issues in women with breast cancer. Psychology, health & medicine. 2008;13(3):313-25.
6. Chang EY, Glissmeyer M, Tonnes S, Hudson T, Johnson N. Outcomes of breast cancer in patients who use alternative therapies as primary treatment. American journal of surgery. 2006;192(4):471-3.
7. Chen SJ, Kung PT, Huang KH, Wang YH, Tsai WC. Characteristics of the Delayed or Refusal Therapy in Breast Cancer Patients: A Longitudinal Population-Based Study in Taiwan. PLoS One. 2015;10(6):e0131305.
8. Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. American journal of surgery. 2000;179(5):407-11.
9. Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D, et al. Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. Journal of the National Cancer Institute. Monographs. 2014;2014(50):346-58.
10. Johnson SB, Park HS, Gross CP, Yu JB. Use of Alternative Medicine for Cancer and Its Impact on Survival. Journal of the National Cancer Institute. 2018;110(1).
11. Joseph K, Vrouwe S, Kamruzzaman A, Balbaid A, Fenton D, Berendt R, et al. Outcome analysis of breast cancer patients who declined evidencebased treatment. World journal of surgical oncology. 2012;10:118.
12. Tae Y, Kwon S, Lee Y, Bae J. Endless Management of Mind and Body for Healing : The Process of Pursuing Complementary and Alternative Medicine in Patients with Breast Cancer. Korean Journal of Adult Nursing. 2015;27(6):728-41.
13. Citrin DL, Bloom DL, Grutsch JF, Mortensen SJ, Lis CG. Beliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapies. The oncologist. 2012;17(5):607-12.
14. Liao GS, Apaya MK, Shyur LF. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evidence-based complementary and alternative medicine : eCAM. 2013;2013:437948.
15. Seo E, Kim S, Bae N, Choi A. Beneficial Effect of Hyangsayangwi-tang on the Cisplatin-Induced Gastrointestinal Dysfunctions in Rats. J Sasang Constitut Med. 2013;25(4):343-58.
16. Song H, Kim D, Kim S. Effect of Hyangsayangwetang and Kamihyangsayangwetang on Antitumor Activity and Reduction of Side Effect. The Journal of Kyung Hee University Medical Center. 1995;11(3-4):320-38.